GUIDELINES FOR HORMONE TREATMENT OF WOMEN IN THE MENOPAUSAL TRANSITION AND BEYOND Position Statement by the Executive Committee of the International Menopause Society

F. Naftolin; H. P. G. Schneider; D. W. Sturdee; M. Birkhäuser; M. P. Brincat; M. Gambacciani; A. R. Genazzani; K. K. Limpaphayom; S. O’Neil; S. Palacios; A. Pines; N. Siseles; D. Tan; H. G. Burger

Lijecnicki vjesnik 2005;127(3-4)

GUIDELINES FOR HORMONE TREATMENT OF WOMEN IN THE MENOPAUSAL TRANSITION AND BEYOND Position Statement by the Executive Committee of the International Menopause Society

F. Naftolin, H. P. G. Schneider, D. W. Sturdee, M. Birkhäuser, M. P. Brincat, M. Gambacciani, A. R. Genazzani, K. K. Limpaphayom, S. O’Neil, S. Palacios, A. Pines, N. Siseles, D. Tan, H. G. Burger

Abstract

The text presents the position of the Executive Committee of the International Menopause Society on hormonal treatment of perimenopausal and postmenopausal women. The occasion is new reports on the risks of hormone therapy, especially in relation to vascular diseases, breast cancer and effects on the brain. The distinction between hormone replacement treatment in symptomatic women and the use of hormones in women without symptoms is emphasized, as well as the need for an individual assessment of benefits and risks.

PDF